Nova EYE Medical Limited (ASX:EYE) has lodged an initial director's interest notice with the ASX for newly appointed director Thomas George Duthy, disclosing that he holds nil relevant interests in the company's securities at the time of his appointment on 29 October 2026.

Key Points

  • Thomas George Duthy was appointed as a director of Nova EYE Medical Limited on 29 October 2026.
  • The initial director's interest notice was lodged under ASX listing rule 3.19A.1 and section 205G of the Corporations Act.
  • Duthy holds nil securities as a registered holder in Nova EYE Medical at the date of appointment.
  • Duthy also holds nil relevant interests in securities of which he is not the registered holder, and has no notifiable interests in contracts.

Appointment of Thomas George Duthy to Nova EYE Medical Board

Nova EYE Medical Limited, registered with ABN 15 007 702 927, disclosed the appointment of Thomas George Duthy to its board of directors, with the appointment date recorded as 29 October 2026. The filing was submitted in accordance with ASX listing rule 3.19A.1, which requires entities to provide an initial director's interest notice to the ASX upon the appointment of a new director. The notice was lodged by the entity acting as agent for the director under section 205G of the Corporations Act.

Director's Registered and Non-Registered Security Holdings

According to the filing, Thomas George Duthy holds nil securities in Nova EYE Medical Limited as a registered holder, as disclosed under Part 1 of the Appendix 3X initial director's interest notice. Part 2 of the filing, which covers relevant interests in securities of which the director is not the registered holder, also records nil holdings. No circumstances giving rise to any relevant interest in securities held by another party on behalf of the director were disclosed in the notice.

Director's Interests in Contracts

Part 3 of the initial director's interest notice addresses Thomas George Duthy's interests in contracts as defined under the notifiable interest provisions of the Corporations Act. The filing records the detail of contract as not applicable and discloses no securities to which any such interest relates. No registered holder of issued securities connected to the director's contract interests was identified, consistent with the nil and not applicable disclosures across all three parts of the Appendix 3X notice submitted to the ASX.